175 related articles for article (PubMed ID: 31084772)
1. PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma.
Kostakoglu L; Chauvie S
PET Clin; 2019 Jul; 14(3):317-329. PubMed ID: 31084772
[TBL] [Abstract][Full Text] [Related]
2. PET imaging for response assessment in lymphoma: potential and limitations.
Schöder H; Moskowitz C
Radiol Clin North Am; 2008 Mar; 46(2):225-41, viii. PubMed ID: 18619378
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of therapy for lymphoma.
Jerusalem G; Hustinx R; Beguin Y; Fillet G
Semin Nucl Med; 2005 Jul; 35(3):186-96. PubMed ID: 16098292
[TBL] [Abstract][Full Text] [Related]
4. Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma.
Adams HJA; Kwee TC
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):342-343. PubMed ID: 27783106
[No Abstract] [Full Text] [Related]
5. Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma.
Fallanca F; Alongi P; Incerti E; Gianolli L; Picchio M; Kayani I; Bomanji JB
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):344-345. PubMed ID: 27796542
[No Abstract] [Full Text] [Related]
6. When should FDG-PET be used in the modern management of lymphoma?
Barrington SF; Mikhaeel NG
Br J Haematol; 2014 Feb; 164(3):315-28. PubMed ID: 24131306
[TBL] [Abstract][Full Text] [Related]
7. Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies.
Raynor WY; Zadeh MZ; Kothekar E; Yellanki DP; Alavi A
PET Clin; 2019 Jul; 14(3):331-340. PubMed ID: 31084773
[TBL] [Abstract][Full Text] [Related]
8. The role of FDG PET in the management of lymphoma: practical guidelines.
Kirby AM; George Mikhaeel N
Nucl Med Commun; 2007 May; 28(5):355-7. PubMed ID: 17414884
[TBL] [Abstract][Full Text] [Related]
9. The role of FDG PET in the management of lymphoma: what is the evidence base?
Kirby AM; Mikhaeel NG
Nucl Med Commun; 2007 May; 28(5):335-54. PubMed ID: 17414883
[TBL] [Abstract][Full Text] [Related]
10. Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.
Wright CL; Maly JJ; Zhang J; Knopp MV
PET Clin; 2017 Jan; 12(1):63-82. PubMed ID: 27863567
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J
Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558
[TBL] [Abstract][Full Text] [Related]
12. FDG PET and PET/CT imaging in lymphoma and melanoma.
Macapinlac HA
Cancer J; 2004; 10(4):262-70. PubMed ID: 15383207
[TBL] [Abstract][Full Text] [Related]
13. The value of F-18 FDG triple-head coincidence PET in the posttreatment evaluation of patients with lymphoma.
Huić D; Mutvar A; Radman I; Grosev D; Labar B; Zuvić M; Dodig D; Aurer I; Nemet D
Clin Nucl Med; 2006 May; 31(5):275-8. PubMed ID: 16622336
[No Abstract] [Full Text] [Related]
14. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Tumor Volume Metrics in Lymphoma.
Kostakoglu L; Chauvie S
Semin Nucl Med; 2018 Jan; 48(1):50-66. PubMed ID: 29195618
[TBL] [Abstract][Full Text] [Related]
16. Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Goudarzi B; Jacene HA; Wahl RL
Acad Radiol; 2010 Sep; 17(9):1175-85. PubMed ID: 20634105
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT in the management of lymphomas: current status and future directions.
El-Galaly TC; Villa D; Gormsen LC; Baech J; Lo A; Cheah CY
J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234
[TBL] [Abstract][Full Text] [Related]
18. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
Barrington SF; Mikhaeel NG; Kostakoglu L; Meignan M; Hutchings M; Müeller SP; Schwartz LH; Zucca E; Fisher RI; Trotman J; Hoekstra OS; Hicks RJ; O'Doherty MJ; Hustinx R; Biggi A; Cheson BD
J Clin Oncol; 2014 Sep; 32(27):3048-58. PubMed ID: 25113771
[TBL] [Abstract][Full Text] [Related]
19. PET and PET/CT for response evaluation in lymphoma: current practice and developments.
Brepoels L; Stroobants S; Verhoef G
Leuk Lymphoma; 2007 Feb; 48(2):270-82. PubMed ID: 17325886
[TBL] [Abstract][Full Text] [Related]
20. Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.
Ayers EC; Fardin S; Gholami S; Alavi A; Mato AR
PET Clin; 2016 Jul; 11(3):209-18. PubMed ID: 27321026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
